Balyasny Asset Management LLC Natera, Inc. Transaction History

Balyasny Asset Management LLC

$54.8 Billion
Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Natera, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 189,357 shares of NTRA stock, worth $20.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

189,357

Previous 327,359 42.16%

Holding current value

$20.5 Million

Previous $20.5 Million 15.54%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$59.21 - $92.9 $8.17 Million - $12.8 Million	-138,002 Reduced 42.16%	189,357 $17.3 Million
Q4 2023 Feb 14, 2024	SELL	$37.55 - $62.64 $7.84 Million - $13.1 Million	-208,838 Reduced 38.95%	327,359 $20.5 Million
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $9.05 Million - $13 Million	-208,588 Reduced 28.01%	536,197 $23.7 Million
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $25.4 Million - $29.8 Million	539,462 Added 262.74%	744,785 $36.2 Million
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $4.68 Million - $7.46 Million	127,934 Added 165.31%	205,323 $11.4 Million

Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $2.64 Million - $3.71 Million	77,389 New	77,389 $3.11 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $32.5 Million - $51.4 Million	1,154,457 Added 4004.64%	1,183,285 $41.9 Million
Q1 2022 May 16, 2022	SELL	$30.32 - $91.33 $4.89 Million - $14.7 Million	-161,116 Reduced 84.82%	28,828 $1.17 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $9.04 Million - $12.5 Million	-104,761 Reduced 35.55%	189,944 $17.7 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $23.8 Million - $30 Million	-237,371 Reduced 44.61%	294,705 $32.8 Million
Q2 2021 Aug 16, 2021	BUY	$86.05 - $119.72 $26.7 Million - $37.1 Million	309,802 Added 139.38%	532,076 $60.4 Million
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $19.3 Million - $26.2 Million	-210,706 Reduced 48.66%	222,274 $22.6 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $9.91 Million - $16.6 Million	148,640 Added 52.28%	432,980 $43.1 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $13 Million - $20.7 Million	284,340 New	284,340 $20.5 Million
Q2 2020 Aug 14, 2020	SELL	$26.36 - $49.86 $5.13 Million - $9.7 Million	-194,614 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.27 - $40.17 $3.16 Million - $7.34 Million	182,741 Added 1539.13%	194,614 $5.81 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $381,123 - $479,669	11,873 New	11,873 $400,000
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $795,661 - $1.24 Million	-44,826 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.34 - $20.62 $345,495 - $628,229	30,467 Added 212.18%	44,826 $924,000
Q4 2018 Feb 14, 2019	BUY	$12.32 - $24.38 $68,240 - $135,040	5,539 Added 62.8%	14,359 $200,000
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $165,992 - $255,427	8,820 New	8,820 $211,000
Q2 2018 Aug 14, 2018	SELL	$8.79 - $19.98 $104,600 - $237,762	-11,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.0 - $11.95 $107,100 - $142,205	11,900 New	11,900 $110,000

Others Institutions Holding NTRA

# of Institutions

439

Shares Held

117M

Call Options Held

254K

Put Options Held

263K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Natera, Inc. Transaction History